Addus HomeCare (NASDAQ:ADUS) Posts Earnings Results, Misses Expectations By $0.09 EPS

Addus HomeCare (NASDAQ:ADUS) issued its earnings results on Monday. The company reported $1.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.35 by ($0.09), Zacks reports. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The firm had revenue of $297.14 million during the quarter, compared to the consensus estimate of $291.04 million.

Addus HomeCare Price Performance

Shares of Addus HomeCare stock opened at $97.53 on Wednesday. Addus HomeCare has a 1 year low of $85.94 and a 1 year high of $136.72. The firm has a market cap of $1.77 billion, a price-to-earnings ratio of 22.32, a PEG ratio of 1.41 and a beta of 1.00. The company has a 50-day moving average of $123.94 and a 200 day moving average of $126.50.

Analyst Ratings Changes

ADUS has been the topic of a number of analyst reports. Stephens boosted their price objective on shares of Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a research report on Wednesday, November 6th. Macquarie reissued an “outperform” rating and issued a $139.00 target price on shares of Addus HomeCare in a research note on Monday, November 4th. Citizens Jmp raised Addus HomeCare to a “strong-buy” rating in a research report on Monday, December 16th. Oppenheimer lifted their price objective on Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. Finally, Royal Bank of Canada restated an “outperform” rating and set a $136.00 target price on shares of Addus HomeCare in a report on Thursday, November 14th. One research analyst has rated the stock with a sell rating, eight have issued a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, Addus HomeCare has an average rating of “Buy” and an average target price of $134.22.

Insider Buying and Selling

In other Addus HomeCare news, EVP Roberton James Stevenson sold 2,250 shares of the business’s stock in a transaction on Monday, December 9th. The stock was sold at an average price of $121.00, for a total value of $272,250.00. Following the sale, the executive vice president now directly owns 10,217 shares of the company’s stock, valued at approximately $1,236,257. The trade was a 18.05 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO R Dirk Allison sold 25,000 shares of the company’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the completion of the transaction, the chief executive officer now owns 79,397 shares in the company, valued at approximately $9,905,569.72. The trade was a 23.95 % decrease in their position. The disclosure for this sale can be found here. 4.60% of the stock is currently owned by insiders.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.